![Robert Hale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Hale
Direttore/Membro del Consiglio presso
OLYMPUS CORPORATION
Profilo
Mr. David R.
Hale is a Co-Chief Executive Officer at ValueAct Capital Management LP.
He is on the Board of Directors at Olympus Corp.
Mr. Hale was previously employed as an Independent Outside Director by JSR Corp., an Independent Director by Bausch Health Cos., Inc. and by MSCI, Inc., an Analyst by Strategic Value Capital, and a Senior Associate by The Parthenon Group LLC.
He received his AB Classics degree from Dartmouth College.
Posizioni attive di Robert Hale
| Società | Posizione | Inizio |
|---|---|---|
| OLYMPUS CORPORATION | Direttore/Membro del Consiglio | 01/06/2019 |
ValueAct Capital Management LP
 ValueAct Capital Management LP Investment ManagersFinance ValueAct Capital employs long-term, concentrated, active value investing in a select number of companies. They regularly hold positions for 3-5 years. The firm utilizes financial instruments both for investment purposes and to seek to hedge against fluctuations in the value of the private funds’ portfolios as a result of changes in currency exchange rates, market interest rates, and equity prices. ValueAct Capital is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Amministratore Delegato | 01/08/2023 |
Precedenti posizioni note di Robert Hale
| Società | Posizione | Fine |
|---|---|---|
| BAUSCH HEALTH COMPANIES INC. | Direttore/Membro del Consiglio | 19/06/2021 |
| MSCI, INC. | Direttore/Membro del Consiglio | 27/09/2016 |
The Parthenon Group LLC
 The Parthenon Group LLC Investment ManagersFinance Provides strategic advisory and principal investment services | Corporate Officer/Principal | 31/12/2010 |
Strategic Value Capital
 Strategic Value Capital Investment ManagersFinance Strategic Value Capital focuses on long/short investments in the stocks of small- and mid-cap companies | Corporate Officer/Principal | 30/11/2010 |
| JSR CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Robert Hale
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
60
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
ValueAct Capital Management LP
ValueAct Capital Management LP Investment ManagersFinance ValueAct Capital employs long-term, concentrated, active value investing in a select number of companies. They regularly hold positions for 3-5 years. The firm utilizes financial instruments both for investment purposes and to seek to hedge against fluctuations in the value of the private funds’ portfolios as a result of changes in currency exchange rates, market interest rates, and equity prices. ValueAct Capital is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olympus Corp.
 Olympus Corp. Medical SpecialtiesHealth Technology Manufactures and sells precision machineries and instruments | Health Technology |
JSR Corp.
 JSR Corp. Industrial MachineryProducer Manufacturing Manufactures lithography, process and deposition material for semiconductor devices | Producer Manufacturing |
The Parthenon Group LLC
The Parthenon Group LLC Investment ManagersFinance Provides strategic advisory and principal investment services | Finance |
MSCI, Inc.
 MSCI, Inc. Financial Publishing/ServicesCommercial Services Provides investment decision support applications to investment institutions worldwide | Commercial Services |
Strategic Value Capital
Strategic Value Capital Investment ManagersFinance Strategic Value Capital focuses on long/short investments in the stocks of small- and mid-cap companies | Finance |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
